Literature DB >> 813534

Renovascular resistance and noradrenaline.

L Bomzon, C Rosendorff.   

Abstract

Stimulation of the renal nerves can cause cortical vasoconstriction either by direct activation of vascular smooth muscle or by the generation of angiotensin II following renin release from the juxtaglomerular cells. High doses ( greater than 5 mug/min) of the renal neurotransmitter noradrenaline (NA) infused into the renal artery of the baboon causes cortical vasoconstriction. This NA-induced vasoconstriction is significantly reduced (P less than 0.001) by SQ20881, an inhibitor of converting enzyme, and by saralasin, a competitive inhibitor of angiotensin II. These results suggest that NA stimulates the renin-angiotensin mechanism. The further addition of the alpha-adrenergic blocking agent, phenoxybenzamine, to the NA-SQ20881 or NA-saralasin infusate completely abolishes NA-induced cortical vasoconstriction. These results suggest that NA-induced cortical vasoconstriction in the kidney is mediated by activation of both the renin-angiotensin system and alpha-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 813534     DOI: 10.1152/ajplegacy.1975.229.6.1649

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Glucose-insulin-potassium correlates with hemodynamic improvement in patients with septic myocardial dysfunction.

Authors:  Won-Young Kim; Moon Seong Baek; Young Shin Kim; Jarim Seo; Jin Won Huh; Chae-Man Lim; Younsuck Koh; Sang-Bum Hong
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Effect of the inhibitor of angiotensin I converting enzyme on endocrine function and renal perfusion in haemorrhagic shock.

Authors:  M Yamashita; T Oyama; T Kudo
Journal:  Can Anaesth Soc J       Date:  1977-11

Review 3.  Vasopressin versus norepinephrine as the first-line vasopressor in septic shock: A systematic review and meta-analysis.

Authors:  Yub Raj Sedhai; Dhan Bahadur Shrestha; Pravash Budhathoki; Waqas Memon; Roshan Acharya; Suman Gaire; Nisheem Pokharel; Swojay Maharjan; Ranjit Jasaraj; Amik Sodhi; Dipen Kadariya; Ankush Asija; Markos G Kashiouris
Journal:  J Clin Transl Res       Date:  2022-05-25

4.  The effects of vasopressin on acute kidney injury in septic shock.

Authors:  Anthony C Gordon; James A Russell; Keith R Walley; Joel Singer; Dieter Ayers; Michelle M Storms; Cheryl L Holmes; Paul C Hébert; D James Cooper; Sangeeta Mehta; John T Granton; Deborah J Cook; Jeffrey J Presneill
Journal:  Intensive Care Med       Date:  2009-10-20       Impact factor: 17.440

5.  Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).

Authors:  Anthony C Gordon; Alexina J Mason; Gavin D Perkins; Deborah Ashby; Stephen J Brett
Journal:  BMJ Open       Date:  2014-07-03       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.